(NYSE: ALC) Alcon's forecast annual revenue growth rate of 7.19% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.44%.
Alcon's revenue in 2026 is $10,401,000,000.On average, 26 Wall Street analysts forecast ALC's revenue for 2026 to be $5,475,765,253,280, with the lowest ALC revenue forecast at $5,166,248,524,080, and the highest ALC revenue forecast at $5,852,059,607,520. On average, 23 Wall Street analysts forecast ALC's revenue for 2027 to be $5,827,688,211,520, with the lowest ALC revenue forecast at $5,452,856,141,040, and the highest ALC revenue forecast at $6,204,469,993,680.
In 2028, ALC is forecast to generate $6,269,785,334,960 in revenue, with the lowest revenue forecast at $5,871,556,724,320 and the highest revenue forecast at $7,387,944,983,440.